NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









MedeAnalytics

MedeAnalytics

Private
Richardson, TexasHealthcare & Life Scienceshttps://medeanalytics.com/

Last Round

Buyout/LBO

Oct 9, 2020

Est. Valuation

$250M

Total Funding Raised

$57M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

MedeAnalytics is a healthcare analytics company that provides an AI-driven, cloud-native, software-as-a-service platform for healthcare organizations to improve financial, operational, and clinical performance.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Revenue Cycle, Business Intelligence, Data Integration, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

revenue cycle managementRCMhealthcare analyticsvalue-based careVBCpayer analyticshealthcare SaaShealthcare BIhealthtechMedicaid analyticshealthcare financial analyticspopulation healthclinical analyticshealthcare data integrationhealth govtechEHR agnostichealthcare consulting

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MedeAnalytics Comparables

Compare MedeAnalytics with similar companies based on industry and business-model similarity.

MedeAnalytics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Health Catalyst
82%
Arcadia
79%
VisiQuate
77%

MedeAnalytics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Buyout/LBOOct 9, 2020
Buyout/LBOSep 30, 2015
Private EquityJul 29, 2008
Series AApr 1, 2004

Key People

Founding team and executive leadership

Michael Gallagher

Chairman CEO

Executive Team

Steve Grieco

Chief Executive Officer And Board Director

Executive Team

Sree Ghantasala

Chief Technology Officer

Executive Team

Reese Feuerman

Chief Financial Officer

Executive Team

MedeAnalytics Investors

Notable investors and investment history

MedeAnalytics investors
InvestorRounds
Bain Capital VenturesBuyout/LBO, Private Equity
JLL PartnersBuyout/LBO
Kennet PartnersSeries A
Industry VenturesVC Round, Private Equity
Thoma BravoBuyout/LBO
Emergence CapitalVC Round, Private Equity, Buyout/LBO

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Open roles increased to 424, 126% of current headcount.

  • Jul 13, 2026

    Open roles increased to 35, 10% of headcount.

MedeAnalytics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MedeAnalytics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MedeAnalytics's valuation, stock price, and market status.

Firmographic Details

HeadquartersRichardson, Texas
Employee Range337
Year Founded1993
Last FundingOct 9, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.